The last year saw many achievements for Chengdu’s meetings, incentives, conferences and exhibitions (MICE) industry. According to data from the Chengdu Municipal Statistics Bureau, Chengdu hosted 530 major exhibitions, conferences and forums in 2014, of which 214 were exhibitions, 45 more than a year earlier or a year-over-year (YOY) growth rate of 26.6 percent, and 113 were international conferences and forums, 8 more than a year earlier, or a YOY growth rate of 7.6 percent. The events took up 3.25 million square meters of space in the aggregate, a YOY growth rate of 8.0 percent, of which 49 were international in nature, occupying 1.74 million square meters, a YOY growth rate of 16.0 percent. Direct revenue derived from the industry for 2014 totaled 6.95 billion yuan, up 14.9 percent year-on-year while overall revenue (direct plus indirect) revenue reached 58.4 billion yuan, up 14.5 percent year-on-year.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7511651-chengdu-china-mice-industry/
Results from two national surveys of patients receiving chemotherapy and pharmacists, conducted by the Hematology/Oncology Pharmacy Association (HOPA) in collaboration with Eisai Inc.,* found that 83% of patients receiving chemotherapy who have experienced chemotherapy-induced nausea and vomiting (CINV) believe it is a side effect with which they must live. Results also showed that 95% of cancer patients surveyed believe that CINV has, at some point, had an impact on their daily lives. These national surveys are part of the Time to Talk CINV™ campaign, which aims to increase awareness among patients and caregivers about CINV prevention and the importance of speaking with their pharmacist and full healthcare team about this often preventable side effect.
“The survey results underscore the confusion patients who are undergoing chemotherapy have about CINV and the need for them to understand that there are ways to manage their symptoms so that they do not have to needlessly suffer with CINV,” said Scott Soefje, PharmD, MBA, BCOP, President, Hematology/Oncology Pharmacy Association (HOPA) and Director of Pharmacy at the University Medical Center Brackenridge in Austin, TX. “It is imperative that patients discuss CINV prevention early in treatment and with all members of the health care team, including pharmacists.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7560331-time-to-talk-cinv/
Pivotal Corporation, the Seattle start-up responsible for disrupting the wearable fitness marketplace with its $12 Pivotal Living Band, is pleased to announce pre-order availability for the Pivotal Living Smart Scale, a smarter scale with an even smarter price. Available for $39.95, just a fraction of the cost of most smart scales on the market, the elegant and efficient smart scale integrates seamlessly with the Pivotal Living app to provide a more intelligent way to manage body weight and overall health.
“Our mission has always been to spark a movement toward proactive health and wellness through affordable and powerful, personal health technology,” said David Donovick, CEO for Pivotal Corporation. “We are very proud to introduce a feature-rich smart scale to our family of products and software, and are thrilled to be able to offer it to our members at a pizza-dinner price!”
Using advanced bioimpedance technology, the Pivotal Living Smart Scale accurately measures key body weight and body fat percentage factors, helping people lose weight and stay healthy. Designed to help users identify when they are burning fat, building muscle and losing weight, the sleek smart scale displays weight on the scale’s easy-to-read LCD display screen and, when synced to the Pivotal Living mobile app, sends additional weight and body details. The scale’s four load sensors accurately assess body composition measurements based on weight and height data stored within the app. Working together, the scale and app measure and track.
To view the multimedia release go to:
http://www.multivu.com/players/English/7668051-pivotal-living-bluetooth-smart-scale/
Moët Hennessy, Official Partner, reaffirms its support for Solar Impulse and its pursuit of the first round-the-world flight powered only by solar energy.
"Celebrating Sustainability"
Its support of Solar Impulse as an Official Partner shows Moët Hennessy's taste for pushing the envelope and conquering new territories, as well as recognizing the role of excellence and innovation as two key drivers of progress worldwide.
Growth in the Moët Hennessy group and its 22 prestigious brands has been powered by their pioneering spirit and the conquest of new territories. The first consignment of champagne was dispatched to Russia in 1780 by Veuve Clicquot. Hennessy began exporting cognac to the United States in 1787, two years before the French Revolution, followed by China in 1859. Today, Moët Hennessy exports 95% of its production and is the world's leading producer and exporter of luxury wines and spirits.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7813551-moet-hennessy-solar-impulse/
Moët Hennessy, Official Partner, reaffirms its support for Solar Impulse and its pursuit of the first round-the-world flight powered only by solar energy.
"Celebrating Sustainability"
Its support of Solar Impulse as an Official Partner shows Moët Hennessy's taste for pushing the envelope and conquering new territories, as well as recognizing the role of excellence and innovation as two key drivers of progress worldwide.
Growth in the Moët Hennessy group and its 22 prestigious brands has been powered by their pioneering spirit and the conquest of new territories. The first consignment of champagne was dispatched to Russia in 1780 by Veuve Clicquot. Hennessy began exporting cognac to the United States in 1787, two years before the French Revolution, followed by China in 1859. Today, Moët Hennessy exports 95% of its production and is the world's leading producer and exporter of luxury wines and spirits.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7813551-moet-hennessy-solar-impulse/
LivaNova PLC (NASDAQ:LIVN; LSE: LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, today recognizes that more than one million people in the United States with drug-resistant epilepsy continue to be treated unsuccessfully with drugs, despite the proven effectiveness of non-drug treatment options. LivaNova’s VNS Therapy®, for example, is a medical device treatment specifically designed for people with drug-resistant epilepsy that is already used by more than 85,000 people around the world.
One in three people with epilepsy has the type that is not well controlled with drugs, called drug-resistant epilepsy. For those people, prescribing more medicine is usually not the most effective option. In fact, research shows that if you haven’t found seizure freedom after your first two drugs, there is a 95 percent chance that no drug or combination of drugs will result in seizure freedom.
“Despite what we know about drug-resistant epilepsy, the majority of people affected by this condition will continue to be prescribed additional medications instead of being evaluated for surgery or seen in a specialized epilepsy facility,” said Jason Richey, president of LivaNova’s U.S. Region and general manager of the Neuromodulation Business Franchise. “This treatment gap means over one million individuals in the U.S. with undertreated epilepsy remain at risk for dangerous side effects of continued seizures, including injury, depression, memory issues and death.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7966451-livanova-vns-therapy-epilepsy/
Results from a new national survey released today indicate that our lifestyle exacerbates the challenge of trying to lose weight, making it more difficult than ever for adults to do so. Findings further suggest that adults who are trying to lose weight need a new approach that’s compatible with how we live today.
Specifically, most healthcare professionals and a majority of U.S. adults say losing weight is harder today than it was for previous generations because of the busy, modern lifestyle of Americans (77% of primary care physicians or PCPs, 81% of pharmacists, 62% U.S. adults). In fact, approximately seven in 10 healthcare professionals say it’s harder for Americans today to lose weight compared to just 10 years ago (69% of PCPs, 73% of pharmacists), and the vast majority believe Americans need to take a new approach to weight loss that fits with today’s modern lifestyle (89% of PCPs, 95% of pharmacists).
To view the multimedia release go to:
https://www.multivu.com/players/English/8215151-the-truth-about-weight-loss-national-survey/
Just over half of 2018 model vehicles evaluated by the Insurance Institute for Highway Safety are available with headlights that do an adequate job of lighting the road at night and limiting glare for oncoming drivers, but most good-rated headlights are optional or bundled with other features that can raise the price of the vehicle.
Since IIHS released its first headlight ratings for passenger vehicles in 2016, most manufacturers have focused on improving this key safety component. That year, only 2 of 95 headlight systems on 2016-model vehicles evaluated earned a good rating.
For the 2018 model year, the best-available headlights on 32 of 165 models evaluated earn the highest rating of good, and the best-available headlights on 58 models earn the second-highest rating of acceptable. Thirty-two models have only marginal-rated headlights, while poor-rated headlights are the only ones available for 43 models.
https://domesticsciencehome.co.uk/ Order online today - FREE UK shipping for orders over £50 (*excluding vintage) or a simple flat rate of £3.95 to the UK Mainland (inc Northern Ireland). Described as an Aladdin's Cave by our customers do make time to browse all the floors, then relax with a fresh coffee and enjoy outdoor seating in sunny weather.
Our two mini ‘department’ stores are filled to the brim with a fascinating mix of contemporary and vintage items handpicked from far-flung corners of the globe to inspire and delight, now you can buy our range direct.
Owing to my personal experience, I am 95% convinced that this is also the best prevention method for any viruses, including COVID-19. So here it is:
If your weight is 80 kg (176 lb.) or more, take
One liter of warm water +98.6 F. ( 37°C)
One lemon (squeeze)
Two tablespoons of honey
One teaspoon of baking soda
Mix it and drink in a time of a maximum of 5 minutes! Remember! You have to drink it on an empty stomach in the morning.
